Gland Pharma Limited
GLAND
Hisse Senetlerindeki Sıralama
#3295
Gland Pharma Limited, established in Hyderabad, India, in 1978, is a... Gland Pharma Limited, established in Hyderabad, India, in 1978, is a pharmaceutical company that specializes in the creation, production, and global distribution of generic injectable medications. Its product line features key active pharmaceutical ingredients such as heparin sodium, enoxaparin sodium, rocuronium bromide, and daptomycin injections, among others. The company's extensive therapeutic portfolio encompasses anti-infectives, anesthetics, anticoagulants, antimalarials, cardiovascular drugs, gastrointestinal treatments, pain management, hormones, fertility aids, anti-cancer agents, gynecological remedies, neurological and central nervous system medications, respiratory treatments, blood-related products, ophthalmological and otological solutions, orthopedics, hematinics, and various vitamins, minerals, and nutrients. Additionally, Gland Pharma provides contract development services. The company primarily operates on a business-to-business (B2B) model, distributing its products across major markets including the United States, Europe, Canada, Australia, India, and other international territories. Gland Pharma Limited functions as a subsidiary of Fosun Pharma Industrial Pte. Ltd.
Hisse Fiyatı
$32.32
Son senkronizasyon: 2026-10-21
Piyasa Değeri
$5.33B
Değişim (1 gün)
-3.01%
Değişim (1 yıl)
47.99%
Ülke
IN
Ticaret Gland Pharma Limited (GLAND)
Kategori
Healthcare
Gland Pharma Limited (GLAND) için gelir
Jun 2026 itibarıyla gelir TTM: $742.20M
Gland Pharma Limited şirketinin en son finansal raporlarına göre, mevcut geliri (TTM) $742.20M'dir. 2024 yılında şirketin geliri $679.36M önceki yıla göre artış 2023 yılındaki $441.05M gelirine göre. Gelir, bir şirketin mal veya hizmet satışından elde ettiği toplam tutardır. Kazançtan farklı olarak, hiçbir gider düşülmez.
Gland Pharma Limited için 2017 ile 2026 arasındaki gelir geçmişi
Her yılın sonunda gelir
| Yıl | Gelir | Değiştir |
|---|---|---|
| 2026 (TTM) | $742.20M | 13.02% |
| 2025 | $656.70M | -3.34% |
| 2024 | $679.36M | 54.03% |
| 2023 | $441.05M | -23.92% |
| 2022 | $579.73M | 22.55% |
| 2021 | $473.05M | 35.33% |
| 2020 | $349.54M | 18.74% |
| 2019 | $294.38M | 18.32% |
| 2018 | $248.80M | 9.08% |
| 2017 | $228.10M | 0.00% |
Benzer şirketler veya rakiplerin geliri
| Şirket | Gelir | Gelir Farkı | Ülke |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $6.61B | 790.82% |
IN
|
